These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 19666177)

  • 1. Unique clinicopathological features and PrP profiles in the first autopsied case of dura mater graft-associated Creutzfeldt-Jakob disease with codon 219 lysine allele observed in Japanese population.
    Ikawa M; Yoneda M; Matsunaga A; Nakagawa H; Kazama-Suzuki A; Miyashita N; Naiki H; Kitamoto T; Kuriyama M
    J Neurol Sci; 2009 Oct; 285(1-2):265-7. PubMed ID: 19666177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dura mater graft-associated Creutzfeldt-Jakob disease in Japan: clinicopathological and molecular characterization of the two distinct subtypes.
    Yamada M; Noguchi-Shinohara M; Hamaguchi T; Nozaki I; Kitamoto T; Sato T; Nakamura Y; Mizusawa H
    Neuropathology; 2009 Oct; 29(5):609-18. PubMed ID: 19659940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical features and diagnosis of dura mater graft associated Creutzfeldt Jakob disease.
    Noguchi-Shinohara M; Hamaguchi T; Kitamoto T; Sato T; Nakamura Y; Mizusawa H; Yamada M
    Neurology; 2007 Jul; 69(4):360-7. PubMed ID: 17646628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A traceback phenomenon can reveal the origin of prion infection.
    Kobayashi A; Asano M; Mohri S; Kitamoto T
    Neuropathology; 2009 Oct; 29(5):619-24. PubMed ID: 19659941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathologic characteristics of five autopsied cases of dura mater-associated Creutzfeldt-Jakob disease.
    Iwasaki Y; Mimuro M; Yoshida M; Hashizume Y; Kitamoto T; Sobue G
    Neuropathology; 2008 Feb; 28(1):51-61. PubMed ID: 18181835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An autopsied case of Creutzfeldt-Jakob disease with mutation in the prion protein gene codon 232 and type 1+2 prion protein.
    Iwasaki Y; Yokoi F; Tatsumi S; Mimuro M; Iwai K; Kitamoto T; Yoshida M
    Neuropathology; 2013 Oct; 33(5):568-75. PubMed ID: 23320809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective 10-year surveillance of human prion diseases in Japan.
    Nozaki I; Hamaguchi T; Sanjo N; Noguchi-Shinohara M; Sakai K; Nakamura Y; Sato T; Kitamoto T; Mizusawa H; Moriwaka F; Shiga Y; Kuroiwa Y; Nishizawa M; Kuzuhara S; Inuzuka T; Takeda M; Kuroda S; Abe K; Murai H; Murayama S; Tateishi J; Takumi I; Shirabe S; Harada M; Sadakane A; Yamada M
    Brain; 2010 Oct; 133(10):3043-57. PubMed ID: 20855418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinctive properties of plaque-type dura mater graft-associated Creutzfeldt-Jakob disease in cell-protein misfolding cyclic amplification.
    Takeuchi A; Kobayashi A; Parchi P; Yamada M; Morita M; Uno S; Kitamoto T
    Lab Invest; 2016 May; 96(5):581-7. PubMed ID: 26878132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MM1-type sporadic Creutzfeldt-Jakob disease with unusually prolonged disease duration presenting with panencephalopathic-type pathology.
    Hoshino A; Iwasaki Y; Izumi M; Kimura S; Ibi T; Kitamoto T; Yoshida M; Hashizume Y; Sahashi K
    Neuropathology; 2008 Jun; 28(3):326-32. PubMed ID: 18248577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinicopathological characteristics of Creutzfeldt-Jakob disease with a PrP V180I mutation and M129V polymorphism on different alleles].
    Iwaski Y; Sone M; Kato T; Yoshida E; Indo T; Yoshida M; Hashizume Y; Yamada M
    Rinsho Shinkeigaku; 1999 Aug; 39(8):800-6. PubMed ID: 10586622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of an 11-12 kDa protease-resistant prion protein fragment with subtypes of dura graft-associated Creutzfeldt-Jakob disease and other prion diseases.
    Satoh K; Muramoto T; Tanaka T; Kitamoto N; Ironside JW; Nagashima K; Yamada M; Sato T; Mohri S; Kitamoto T
    J Gen Virol; 2003 Oct; 84(Pt 10):2885-2893. PubMed ID: 13679624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An autopsied case of panencephalopathic-type Creutzfeldt-Jakob disease with mutation in the prion protein gene at codon 232 and type 1 prion protein.
    Hama T; Iwasaki Y; Niwa H; Yoshida M; Hashizume Y; Kitamoto T; Murakami N; Sobue G
    Neuropathology; 2009 Dec; 29(6):727-34. PubMed ID: 19422533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Humanized knock-in mice expressing chimeric prion protein showed varied susceptibility to different human prions.
    Taguchi Y; Mohri S; Ironside JW; Muramoto T; Kitamoto T
    Am J Pathol; 2003 Dec; 163(6):2585-93. PubMed ID: 14633630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dura mater graft-associated Creutzfeldt-Jakob disease with 30-year incubation period.
    Shijo M; Honda H; Koyama S; Ishitsuka K; Maeda K; Kuroda J; Tanii M; Kitazono T; Iwaki T
    Neuropathology; 2017 Jun; 37(3):275-281. PubMed ID: 27925304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transmission properties of atypical Creutzfeldt-Jakob disease: a clue to disease etiology?
    Kobayashi A; Parchi P; Yamada M; Brown P; Saverioni D; Matsuura Y; Takeuchi A; Mohri S; Kitamoto T
    J Virol; 2015 Apr; 89(7):3939-46. PubMed ID: 25609817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autopsied case of non-plaque-type dura mater graft-associated Creutzfeldt-Jakob disease presenting with extensive amyloid-β deposition.
    Iwasaki Y; Imamura K; Iwai K; Kobayashi Y; Akagi A; Mimuro M; Miyahara H; Kitamoto T; Yoshida M
    Neuropathology; 2018 Oct; 38(5):549-556. PubMed ID: 30084170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protease-resistant PrP and PrP oligomers in the brain in human prion diseases after intraventricular pentosan polysulfate infusion.
    Honda H; Sasaki K; Minaki H; Masui K; Suzuki SO; Doh-Ura K; Iwaki T
    Neuropathology; 2012 Apr; 32(2):124-32. PubMed ID: 21801238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Creutzfeldt-Jakob disease with an M232R substitution: report of a patient showing slowly progressive disease with abundant plaque-like PrP deposits in the cerebellum.
    Shimizu H; Yamada M; Matsubara N; Takano H; Umeda Y; Kawase Y; Kitamoto T; Nishizawa M; Takahashi H
    Neuropathology; 2009 Dec; 29(6):735-43. PubMed ID: 19422537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Molecular genetics in Creutzfeldt-Jakob disease].
    Kitamoto T
    Rinsho Shinkeigaku; 1994 Dec; 34(12):1222-3. PubMed ID: 7774117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [An autopsy-verified case of Creutzfeldt-Jakob disease with codon 129 polymorphism and codon 180 point mutation].
    Matsumura T; Kojima S; Kuroiwa Y; Takagi A; Unakami M; Kitamoto T
    Rinsho Shinkeigaku; 1995 Mar; 35(3):282-5. PubMed ID: 7614752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.